7/24/26 17:59 | 6/26/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Pande Atul | NC | D | | 8 | M.d | 448 | 21.35 | 0 | 21 | 18 | 137 | D | | | | | | | | | | | | | | |
7/24/26 17:59 | 6/26/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Pande Atul | NC | D | | 8 | S.d | -448 | 21.35 | 0 | -21 | | 137 | D | | | | | | | | | | | | | | |
7/24/26 17:57 | 6/26/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Girao Tiago | NC | O | CFO | 3 | M.d | 807 | 30.10 | 0 | 27 | 12 | 248 | D | | | | | | | | | | | | | | |
7/24/26 17:57 | 6/26/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Girao Tiago | NC | O | CFO | 3 | S.d | -807 | 30.10 | 0 | -27 | | 248 | D | | | | | | | | | | | | | | |
7/24/26 17:57 | 7/8/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Stout Jay S | NC | O | CTO | 3 | S | -1,781 | 38.43 | 0 | -46 | | 212 | D | | | | | | | | | | | | | | |
7/10/26 16:15 | 7/8/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Gloria Melanie | NC | O | COO | 3 | S | -860 | 37.62 | 0 | -23 | | 242 | D | | | | | | | | | | | | | | |
7/10/26 16:13 | 6/18/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Van Tuyl Christopher | NC | O | GC | 4 | S.d | -1,095 | 27.72 | 0 | -39 | | 181 | D | | | | | | | | | | | | | | |
7/6/26 17:01 | 7/1/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Venker Eric | NC | DO | CEO | 2 | M.d | 1,452 | 15.24 | 0 | 95 | 60 | 254 | D | | | | | | | | | | | | | | |
7/6/26 17:01 | 7/2/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Venker Eric | NC | DO | CEO | 2 | S.d | -1,452 | 15.24 | 0 | -95 | | 254 | D | | | | | | | | | | | | | | |
5/29/26 16:04 | 5/28/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Fromkin Andrew J. | NC | D | | 2 | M.d | 9,053 | 21.63 | 0 | 419 | | 74 | D | | | | | | | | | | | | | | |
5/29/26 16:04 | 5/28/26 | IMVT | Health | BioPrd | Biological Products, (No Diag | Fromkin Andrew J. | NC | D | | 2 | S.d | -9,053 | 21.63 | 0 | -419 | | 74 | D | | | | | | | | | | | | | | |